Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Adaptive Biotechnologies Corporation, 3 years.
Adaptive Biotechnologies Corporation
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 25, 2026 | Adaptive Biotechnologies Corporation | Option exercise | +52,084 | $7.80 | $406,255 |
| Jun 25, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −52,084 | $20.18 | $1,051,055 |
| Mar 11, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −15,394 | $13.91 | $214,131 |
| Mar 4, 2026 | Adaptive Biotechnologies Corporation | Grant or award | +15,625 | — | — |
| Mar 3, 2026 | Adaptive Biotechnologies Corporation | Option exercise | +48,044 | $3.99 | $191,696 |
| Mar 3, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −48,044 | $15.30 | $735,073 |
| Mar 13, 2025 | Adaptive Biotechnologies Corporation | Open-market sale | −36,291 | $7.19 | $260,932 |
| Mar 6, 2025 | Adaptive Biotechnologies Corporation | Open-market sale | −15,664 | $7.94 | $124,372 |
| Mar 4, 2025 | Adaptive Biotechnologies Corporation | Grant or award | +15,394 | — | — |
| Mar 4, 2024 | Adaptive Biotechnologies Corporation | Grant or award | +31,328 | — | — |
| Mar 27, 2023 | Adaptive Biotechnologies Corporation | Open-market sale | −2,341 | $8.49 | $19,875 |
| Mar 6, 2023 | Adaptive Biotechnologies Corporation | Grant or award | +14,775 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.